The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases | BenthamScience

The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases

Author(s): Gholamreza Azizi, Hassan Abolhassani, Mohammad Hosein Asgardoon, Javad Rahnavard, Majid Zaki dizaji, Reza Yazdani, Javad Mohammadi, Asghar Aghamohammadi.

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets

Volume 16 , Issue 2 , 2016


Immunoglobulin therapy represents a lifesaving intervention for many patients with primary immunodeficiency (PID). Antibody defects represent approximately half of the well-known PIDs requiring immunoglobulin replacement therapy. Following immunoglobulin therapy in PID patients, protection against serious upper and lower respiratory tract infections and pulmonary function improves which leads to an increase in the quality of life of these patients. Successful treatment of PID patients depends on the type of immunodeficiency, regular monitoring of the patient, comorbidities of the patient, and the availability of the products.

Keywords: Immunoglobulin, infection, primary antibody deficiency, primary immunodeficiency diseases.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Page: [80 - 88]
Pages: 9
DOI: 10.2174/1871530316666160724214418

Article Metrics

PDF: 34